Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Adam Julian Cohen-Nowak
Observed names:
Adam Cohen-Nowak,
Adam Cohen‐Nowak,
Adam J. Cohen-Nowak,
Adam J. Cohen‐Nowak
Institution:
Northwestern University
Observed institutions:
The Wistar Institute,
Northwestern University,
Thomas Jefferson University,
Northwestern Memorial Hospital,
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
ORCID:
0000-0001-6784-7159
Observed ORCID:
0000-0001-6784-7159
OpenAlex ID:
A5084597040
MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer
2020
·
Jessica C. Casciano
, Caroline Perry
, et al.
·
British Journal of Cancer
·
80
PDF
Role of immunotherapy in chondrosarcoma: A case report and review of the literature
2023
·
Adam J. Cohen-Nowak
, Danielle B. Dressler
, et al.
·
Therapeutic Advances in Medical Oncology
·
16
Modern Management and Diagnostics in HER2+ Breast Cancer with CNS Metastasis
2023
·
Surbhi Warrior
, Adam Cohen-Nowak
, et al.
·
Cancers
·
11
PDF
Diagnostics and Screening in Breast Cancer with Brain and Leptomeningeal Metastasis: A Review of the Literature
2024
·
Adam J. Cohen-Nowak
, Virginia B. Hill
, et al.
·
Cancers
·
9
Omaveloxolone attenuates squamous cell carcinoma growth and disease severity in an Epidermolysis Bullosa mouse model
2022
·
Adam J. Cohen‐Nowak
, Alexa J. Cohen
, et al.
·
Experimental Dermatology
·
9
Novel approaches to treatment of leptomeningeal metastases
2023
·
Ditte Primdahl
, Adam Cohen-Nowak
, et al.
·
Current Opinion in Neurology
·
8
Linear basal cell nevus with a novel mosaic PTCH1 mutation
2020
·
Amir Hossein Saeidian
, Adam Cohen‐Nowak
, et al.
·
Experimental Dermatology
·
6
Clinical Characteristics and Outcomes of Mixed Phenotype Acute Leukemia (MPAL): A Large Multi-Center Retrospective Study
2024
·
Adam Julian Cohen-Nowak
, Alexander Coltoff
, et al.
·
Blood
·
2
Hypomethylating agent with venetoclax versus hypomethylating agent alone in frontline management of myelodysplastic syndrome - impact of subgroups on clinical outcomes
2025
·
Guru Subramanian Guru Murthy
, Yasmin Abaza
, et al.
·
Blood
·
1
PDF
Clinical Utilization and Outcomes of Hypomethylating Agents and Venetoclax in Patients with Myelodysplastic Syndrome - a Multicenter Retrospective Analysis
2024
·
Guru Subramanian Guru Murthy
, Somedeb Ball
, et al.
·
Blood
·
1
PDF
Purine-Analog Based Intensive Chemotherapy (IC) Combined with Venetoclax (VEN) Is Highly Active in Newly Diagnosed (ND) and Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
2024
·
Curtis A Lachowiez
, Adam Julian Cohen-Nowak
, et al.
·
Blood
·
1
PDF
Characteristics and Outcomes of Younger Adult Patients (Pts) with Myelodysplastic Syndromes (MDS): A Multicenter Retrospective Study
2023
·
Yasmin Abaza
, Zhuoer Xie
, et al.
·
Blood
PDF
Plasma exosome miR-155-5p as an independent prognostic risk factor for Mycosis Fungoides
2020
·
Adam Cohen‐Nowak
, Neda Nikbakht
·
The Medicine Forum
PDF
Abstract 1441: MYC expression promotes lipid metabolism and metabolic plasticity in human mammary epithelial cells
2018
·
Jessica C. Casciano
, Adam Cohen-Nowak
, et al.
·
Cancer Research
Show more works
View as search
Works count:
14
Citation count:
144
H-index:
6
I10-index:
3
Year
Topic
Type
